OUTCOMES OF LYMPHADENECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: A PROPENSITY SCORE-WEIGHTED ANALYSIS

被引：0
|
作者：
Farber, Nicholas
Rivera-Nunez, Zorimar
Kim, Sinae
Radadia, Kushan
Modi, Parth
Goyal, Sharad
Parikh, Rahul
Weiss, Robert
Kim, Isaac
Elsamra, Sammy
Jang, Thomas
Singer, Eric
机构：
来源：
JOURNAL OF UROLOGY | 2018年 / 199卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP36-01
引用
收藏
页码：E456 / E456
页数：1
相关论文
共 50 条
  • [1] Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database
    Farber, Nicholas J.
    Rivera-Nunez, Zorimar
    Kim, Sinae
    Shinder, Brian
    Radadia, Kushan
    Sterling, Joshua
    Modi, Parth K.
    Goyal, Sharad
    Parikh, Rahul
    Mayer, Tina M.
    Weiss, Robert E.
    Kim, Isaac Y.
    Elsamra, Sammy E.
    Jang, Thomas L.
    Singer, Eric A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (01) : 26 - 32
  • [2] Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database
    Rui Mao
    Hong Zhao
    Kan Li
    Sheng Luo
    Megan Turner
    Jian-Qiang Cai
    Dan Blazer
    Annals of Surgical Oncology, 2019, 26 : 2722 - 2729
  • [3] Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database
    Mao, Rui
    Zhao, Hong
    Li, Kan
    Luo, Sheng
    Turner, Megan
    Cai, Jian-Qiang
    Blazer, Dan, III
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (09) : 2722 - 2729
  • [4] Comparative analysis of outcomes of neoadjuvant and adjuvant systemic therapy in non-metastatic renal cell carcinoma: A propensity score-matched analysis from the INMARC registry.
    Saitta, Cesare
    Nguyen, Mimi
    Hakimi, Kevin
    Afari, Jonathan
    Patil, Dattatraya H.
    Tanaka, Hajime
    Wang, Luke
    Meagher, Margaret F.
    Liu, Franklin
    Puri, Dhruv
    Cerrato, Clara
    Yuen, Kit
    Kobayashi, Masaki
    Fukuda, Shohei
    Master, Viraj A.
    Fujii, Yasuhisa
    Lane, Brian R.
    Derweesh, Ithaar H.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [5] Prognostic value of the geriatric nutritional risk index in patients with non-metastatic clear cell renal cell carcinoma: a propensity score matching analysis
    Zhou, Huiyu
    Lv, Dingyang
    Cui, Fan
    Li, Jinshuai
    Wen, Jie
    Jia, Mohan
    Kang, Yinbo
    Rong, Yi
    Zhang, Wenlong
    Shuang, Weibing
    NUTRITION JOURNAL, 2024, 23 (01)
  • [6] RETROPERITONEAL LYMPH NODE DISSECTION IS NOT ASSOCIATED WITH SURVIVAL OUTCOMES AMONG PATIENTS UNDERGOING RADICAL NEPHRECTOMY FOR NON-METASTATIC RENAL CELL CARCINOMA: A PROPENSITY-SCORE BASED ANALYSIS
    Gershman, Boris
    Moreira, Daniel
    Thompson, R. Houston
    Boorjian, Stephen
    Lohse, Christine
    Costello, Brian
    Cheville, John
    Leibovich, Bradley
    JOURNAL OF UROLOGY, 2016, 195 (04): : E830 - E830
  • [7] Considerations for using multiple imputation in propensity score-weighted analysis
    Eiset, Andreas Halgreen
    Frydenberg, Morten
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2021, 50 : 67 - 69
  • [8] Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis
    Hu, Xu
    Shao, Yan-Xiang
    Yang, Zhi-Qiang
    Dou, Wei-Chao
    Xiong, San-Chao
    Li, Xiang
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [9] Preoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis
    Xu Hu
    Yan-Xiang Shao
    Zhi-Qiang Yang
    Wei-Chao Dou
    San-Chao Xiong
    Xiang Li
    Cancer Cell International, 20
  • [10] Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma
    An, Josiah
    Packiam, Vignesh T.
    Chennamadhavuni, Adithya
    Richards, Jordan
    Jain, Jayanshu
    Mott, Sarah L.
    Garje, Rohan
    FRONTIERS IN ONCOLOGY, 2022, 11
12345